Terms: = Head and neck cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132 AND Prognosis
19 results:
1. m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and keap1/Nrf2 pathways.
Zhao K; Chen L; Xie Y; Ren N; Li J; Zhai X; Zheng S; Liu K; Wang C; Qiu Q; Peng X; Wang W; Liu J; Che Q; Fan J; Hu H; Liu M
Cancer Lett; 2024 Apr; 587():216735. PubMed ID: 38369001
[TBL] [Abstract] [Full Text] [Related]
2. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via keap1/NRF2 signaling.
Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
[TBL] [Abstract] [Full Text] [Related]
3. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract] [Full Text] [Related]
4. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract] [Full Text] [Related]
5. Caspase-8 mutants activate Nrf2 via phosphorylating SQSTM1 to protect against oxidative stress in esophageal squamous cell carcinoma.
Li L; Feng R; Li Y; Yu X; Liu Y; Zhao Y; Liu Z
Free Radic Biol Med; 2022 Nov; 192():51-62. PubMed ID: 36165926
[TBL] [Abstract] [Full Text] [Related]
6. Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating keap1 expression.
Li P; Liu X; Xing W; Qiu H; Li R; Liu S; Sun H
Mol Cell Biochem; 2022 Apr; 477(4):1295-1308. PubMed ID: 35137328
[TBL] [Abstract] [Full Text] [Related]
7. NRF2 Enables EGFR Signaling in Melanoma Cells.
Kreß JKC; Jessen C; Marquardt A; Hufnagel A; Meierjohann S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916908
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through keap1-NRF2 signaling.
Zeng H; Zhao X; Tang C
Cancer Chemother Pharmacol; 2021 Aug; 88(2):223-233. PubMed ID: 33907880
[TBL] [Abstract] [Full Text] [Related]
9. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
10. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract] [Full Text] [Related]
11. [Expression patterns and prognostic values of Nrf2 and keap1 in nasopharyngeal carcinoma].
Ma XK; Liu JS
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):678-682. PubMed ID: 29771085
[No Abstract] [Full Text] [Related]
12. Gene-expression signature regulated by the keap1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract] [Full Text] [Related]
13. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
Choi M; Kadara H; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Kim K; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Herbst RS; Wistuba II
Ann Oncol; 2017 Jan; 28(1):83-89. PubMed ID: 28177435
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
[TBL] [Abstract] [Full Text] [Related]
15. Disruption of keap1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.
Martinez VD; Vucic EA; Thu KL; Pikor LA; Lam S; Lam WL
Head Neck; 2015 May; 37(5):727-34. PubMed ID: 24596130
[TBL] [Abstract] [Full Text] [Related]
16. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
[TBL] [Abstract] [Full Text] [Related]
17. Association of p62/SQSTM1 excess and oral carcinogenesis.
Inui T; Chano T; Takikita-Suzuki M; Nishikawa M; Yamamoto G; Okabe H
PLoS One; 2013; 8(9):e74398. PubMed ID: 24086340
[TBL] [Abstract] [Full Text] [Related]
18. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
[TBL] [Abstract] [Full Text] [Related]
19. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan.
Lin JD; Chao TC; Sun JH; Ho C; Weng HF
Oncology; 2000 May; 58(4):280-5. PubMed ID: 10838492
[TBL] [Abstract] [Full Text] [Related]
